ZOLL Medical (Nasdaq: ZOLL) reported earnings on Jan. 19. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Jan. 1 (Q1), ZOLL Medical met expectations on revenue and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue grew significantly, and earnings per share increased significantly.

Margins improved across the board.

Revenue details
ZOLL Medical booked revenue of $134 million. The eight analysts polled by S&P Capital IQ foresaw net sales of $133 million. Sales were 18% higher than the prior-year quarter's $113 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions.

EPS details
EPS came in at $0.29. The five earnings estimates compiled by S&P Capital IQ predicted $0.27 per share. GAAP EPS of $0.29 for Q1 were 61% higher than the prior-year quarter's $0.18 per share.

Source: S&P Capital IQ. Quarterly periods. Figures may be non-GAAP to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 58.7%, 450 basis points better than the prior-year quarter. Operating margin was 7.9%, 320 basis points better than the prior-year quarter. Net margin was 5.0%, 160 basis points better than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $147 million. On the bottom line, the average EPS estimate is $0.38.

Next year's average estimate for revenue is $616 million. The average EPS estimate is $1.95.

Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 141 members out of 150 rating the stock outperform, and nine members rating it underperform. Among 53 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 50 give ZOLL Medical a green thumbs-up, and three give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on ZOLL Medical is outperform, with an average price target of $73.13.

The healthcare investing landscape is littered with also-rans and a few major winners. Is ZOLL Medical the right stock for you? Read "Discover the Next Rule-Breaking Multibagger" to learn about a company Motley Fool co-founder David Gardner believes will be a phenomenal success over the next few years. Click here for instant access to this free report.